The High Sensitivity of the Multi-Cancer Detection Test ONCOVERYX-F Offers a Promising Platform for Ovarian Cancer Screening

We evaluated the potential relevance of our multi-cancer detection test, OncoVeryx-F, for ovarian cancer screening. For this, we compared its accuracy with that of CA125-based screening. We demonstrate here that, in contrast to CA125-based detection, OncoVeryx-F detected ovarian cancer with very hig...

Full description

Saved in:
Bibliographic Details
Published in:International journal of women's health 2024-01, Vol.16, p.1-7
Main Authors: Nagarkar, Rajnish, Gopichand, Mamillapalli, Pal, Suparna Kanti, Gupta, Ankur, Saquib, Najmuddin Mohd, Sagar, Ganga, Rao, Kanury V S, Siddiqui, Zaved, Longkumer, Imliwati
Format: Article
Language:English
Subjects:
ca 125
Cancer
Diagnosis
lc-ms/ms
Medical tests
noc
oncoveryx-f
Ovarian cancer
ovc
Short Report
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated the potential relevance of our multi-cancer detection test, OncoVeryx-F, for ovarian cancer screening. For this, we compared its accuracy with that of CA125-based screening. We demonstrate here that, in contrast to CA125-based detection, OncoVeryx-F detected ovarian cancer with very high sensitivity and specificity. Importantly here, Stage I cancers too could be detected with an accuracy of >98%. Furthermore, again unlike CA 125, the detection accuracy of OncoVeryx-F remained comparable in both Caucasian and South Asian/Indian women. Thus, the robustness and accuracy of OncoVeryx-F, particularly for early-stage detection, underscores its potential utility for ovarian cancer screening.
ISSN:1179-1411
1179-1411
DOI:10.2147/IJWH.S444258